MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.
Shi X, Liu Q, Li N, Tu W, Luo R, Mei X, Ma Y, Xu W, Chu H, Jiang S, Du Z, Zhao H, Zhao L, Jin L, Wu W, Wang J.
Shi X, et al. Among authors: du z.
Cell Cycle. 2018;17(16):1967-1978. doi: 10.1080/15384101.2018.1509621. Epub 2018 Sep 17.
Cell Cycle. 2018.
PMID: 30145936
Free PMC article.